A2V (p.Ala2Val) variant of CBL (E3 ubiquitin-protein ligase CBL)

A2V (p.Ala2Val) in CBL (E3 ubiquitin-protein ligase CBL) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.46 / 1. The record also includes population frequency data, experimental measurements, and structural context.

A2V (p.Ala2Val) variant details